Eccrine sweat glands: Expression of transforming growth factor-β and bone morphogenetic protein type I receptors and their intracellular signalling Smad proteins

Acta Dermato-Venereologica

Volumn 79, Issue 3, 1999, Pages 183-186

  Wollina, Uwe ^b   Lange, Dirk ^a   Ten Dijke, Peter ^a   Helden, Carl Henrik ^a   Funa, Keiko ^c  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c NONE

Author keywords

Bone morphogenetic proteins; Smad proteins; Sweat glands; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOEPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SWEAT GLAND;

BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; DNA-BINDING PROTEINS; ECCRINE GLANDS; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GROWTH FACTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032972867     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155599750010922     Document Type: Article

References (30)

1. 1. Heldin C.-H, Miyazono K, ten Dijke P. TGF-β signalling from cell membrane to nucleus via Smad proteins. Nature 1997; 390: 465-471.
2. 2. Massagué J, Hata A, Liu F. TGF-signalling through the Smad pathway. Trends Cell Biol 1997; 7: 187-192.
3. 3. Nakao A, Immamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, et al. TGF beta receptor mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997; 16: 5353-5356.
4. 4. Liu XD, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. Transforming growth factor beta induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Nat Acad Sci USA 1997; 94: 10669-10674.
5. 5. Suzuki A, Chang C, Yingling JM, Wang X.-F, Hemmati-Brivanlou A. Smad5 induces ventral fates in Xenopus embryo. Development Biol 1997; 184: 402-405.
6. 6. Mucsi I, Goldberg HJ. Dominant-negative SMAD-3 interferes with transcriptional activation by multiple agonists. Biochem Biophys Res Commun 1997; 232: 517-521.
7. 7. Kretzsehmar M, Liu F, Hata A, Doody J, Massaguè J. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Develop 1997; 11:984-995.
8. 8. Zhang Y, Musci T, Derynck R. The tumor suppressor Smad4/ DPC4 as a central mediator of Smad function. Current Biol 1997; 7: 270-276.
9. 9. De Caestecker MP, Hemmati P, Larisch-Bloch S, Ajmera R, Roberts AB, Lechleider RJ, Characterization of functional domains within Smad4/DPC4. J Biol Chem 1997; 272: 13690-13696.
10. 10. De Winter JP, Roelen BAJ, ten Dijke P, van der Burg U, van der Eijnden-van Raaaij AJM. DPC4 (SMAD4) mediates transforming growth factor-β 1 (TGF-β 1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 1997; 14: 1891-1899.
11. 11. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 1996; 383: 832-836.
12. 12. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. Smad6 inhibits signalling by the TGF-β super-family. Nature 1997; 389: 622-626.
13. 13. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian Jl., Heuchel R, et al. Identification of Smad7, a TGF-β-inducible antagonist of TGF-ß-signalling. Nature 1997; 389: 631-635.
14. 14. Hayashi H, Abdollah S. Qiu Y, Cai J, Xu Y.-Y, Grinnell BW, et al. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 1997; 89; 1165-1173.
15. 15. Furue M, Kato M, Nakamura K, Nashiro K, Kikuchi K, Okochi H, et al. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma. Int J Cancer 1997; 71; 505-509.
16. 16. Fann MJ, Patterson PH. Activins as candidate cholinergic differentiation factors in vivo. Int Dev Neurosci 1995; 13: 317-330.
17. 17. Waltenberger J, Wanders A, Fellström B, Miyazono K, Heldin C.-H, Funa K. Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol 1993; 151: 1147-1157.
18. 18. Takahashi Y, Tonegawa A, Matsumoto K, Ueno N, Kuroiwa A, Noda M, Nifuji A. BMP-4 mediates interactiong signals between the neural tube and skin along the dorsal midline. Genes Cells 1996; 1: 775-783.
19. 19. Blessing M, Nanney LB, King LE, Jones CM, Hogan BL. Transgenic mice as a model to study the role of TGF-β-related molecules in hair follicles. Genes Dev 1993; 7: 204-215.
20. 20. Blessing M, Schirmacher P, Kaiser S. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol 1996; 135: 227-239.
21. 21. Porras-Reyes BH, Ksander G, Weeks PM. Occurrence and localization of transforming growth faclor-β (TGF-β1, β2) during rabbit skin development. Connect Tissue Res 1993; 29: 203-212.
22. 22. Yamamoto N, Akiyuma S, Katagiri T, Namiki M, Kurokawa T, SudaT. Smad1 and Smad5 act downstream of intracellular signalings of BMP 2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 1997; 238: 574-580.
23. 23. Kretzschmar M, Doody J, Massaguè J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad I. Nature 1997; 389: 618-622.
24. 24. Liu F, Hata A, Baker K, Doody J, Cárcamo J, Harland RM, Massagué J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 1996; 381: 620-622.
25. 25. Yang L, Nakamine H, Kamegai A, Sumitomo S, Mori M. Immunohistochemical evaluation of bone morphogenetic protein (BMP) in mixed tumor of skin. J Dermatol Sci 1994; 8: 96-102.
26. 26. Waltenberger J, Lundin L, Öberg K, Wilander E, Miyazono K, Heldin C.-H, Funa K. Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol 1993; 142: 71-78.
27. 27. Wollina U. Diversity of epithelial skin tumors: thoughts and comments on some basic principles. Recent Res Cancer Res 1993; 128: 153-178.
28. 28. Le Lievre CS, Le Douarin NM. Mesenchymal derivates of the neural crest: analysis of chimaeric quail and chick embryos. J Embryol Exp Morphol 1975; 34: 125-154.
29. 29. Wollina U, Lange D, Funa K, Paus R. Expression of transforming growth factor β isoforms and their receptors during hair growth phases in mice. Histol Histopathol 1996; 11; 431-436.
30. 30. Welker P, Foitzik K, Bulfone-Paus S, Henz BM, Paus R. Hair cycle-dependent changes in the gene expression and protein content of transforming growth factor β1 and β 3 in murine skin. Arch Dermatol Res 1997; 289: 554-557.